Green Cross Health

Showing 1953 articles
Business

AbCellera Biologics: A Valuation Crossroads After Volatile Returns

Shares of antibody discovery firm AbCellera Biologics (ABCL) present a complex picture for investors, with strong one-year gains overshadowed by steep declines over longer horizons. As the stock trades near $3.86, a significant gap emerges between its market price and some analyst fair value estimates, raising questions about its premium valuation in a challenging biotech market.

Business

MGM Resorts Bets Big on Nevada Solar, But Can Green Power Spark a Stock Revival?

MGM Resorts International is powering its Las Vegas Strip operations with a major new solar and battery storage deal. This strategic shift toward renewables comes as the company's stock shows mixed signals, trading below some fair value estimates yet at a high earnings multiple, leaving investors to weigh long-term sustainability against immediate financial metrics.

World

France Tightens Toxin Rules, Sparking Fresh Infant Formula Recalls

Two French infant formula makers have recalled multiple product batches following the government's decision to slash permissible levels of cereulide, a toxin linked to gastrointestinal illness. The move amplifies a global safety crisis that has seen major brands issue recalls across dozens of countries since late last year.